Regeneron Confirms that REGN-COV2 Antibody Cocktail Provided to President Trump Under Compassionate Use Request
October 2, 2020 -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today confirmed that, as announced by the White House Press Secretary, Regeneron provided a single 8 gram dose of REGN-COV2, a cocktail of two monoclonal antibodies, for use by... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 2, 2020 Category: Pharmaceuticals Source Type: clinical trials
Trump administration unveils four executive orders aimed at lowering drug prices
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - July 25, 2020 Category: Cancer & Oncology Source Type: clinical trials
Caribbean Island Urinary Iodine Survey 2018
Condition: Iodine Status (Deficiency / Excess) Intervention: Sponsors: Swiss Federal Institute of Technology; Pan American Health Organization, Washington, D.C. 20037 USA; Northwestern University, Potchefstroom, South Africa; United Nations Children's Fund, New York, USA Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2020 Category: Research Source Type: clinical trials